Digital Digital health’s rapid growth spurt comes home to roost With fears of a recession and inflation running high, the boom period for digital health apps looks to be waning.
Digital Pharma’s digital inflection point Billed as the world’s most influential technology event, this year’s CES show saw its first ever keynote from a healthcare company when Abbott CEO Robert Ford took to the stage in Las Vegas
Digital Making sense of differing digital health funding reports Digital health venture funding had a ridiculous, bonkers, blockbuster year.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
